동물용 항감염제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 종별, 약품 유형별, 투여 모드별, 유통 채널별 및 지역별

Veterinary Anti-Infectives Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 12,055,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 15,042,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 동물용 항감염제 시장 규모는 북미가 가장 수익성이 높은 지역으로 부상하는 등 세력 구도가 크게 변화하고 있습니다. 이러한 추세는 반려동물 사육 증가, 동물 영양 강화에 대한 수요 증가, 식품 안전에 대한 관심 증가에 기인합니다. 또한, 반려동물 보험의 도입이 증가하고 있으며, 미국 내 가입률은 연간 10%의 놀라운 성장률을 보이고 있습니다.

북미 시장은 미국이 주도하고 있으며, 예측 기간 동안 75% 이상의 점유율을 차지할 것으로 예상됩니다. 캐나다도 CAGR 4%로 예상되며 강력한 성장세를 보이고 있습니다. 북미 시장 규모 점유율은 15억 달러 이상에 달할 것으로 예상됩니다.

한편, 아시아태평양은 소동물 관리 촉진, 축산 부문의 번영, 인도에서의 판매 제휴에 주력하는 주요 기업들에 의해 빠르게 성장하고 있습니다.

세계 동물용 항감염제 시장을 주도하는 것은 항균제 부문이며, 그 뒤를 이어 항바이러스제가 근소한 차이로 뒤를 잇고 있습니다. 항균제 부문에서는 페니실린, 세팔로스포린, 테트라사이클린 계열이 높은 성장률을 보이고 있습니다. 항바이러스제 부문은 평가 기간 동안 시장 매력도 지수가 1.2로 약품군별로 두 번째로 유리한 부문이 될 것으로 예측됩니다.

생물학적 제제 및 전문 의약품은 세계 동물용 항감염제 시장의 주요 시장 진출기업들에게 큰 기회가 될 것입니다. 과거 R&D에 대한 낮은 수익성이 신제품 개발(NPD)에 대한 수요를 촉진하고 있습니다. R&D, 특히 생물학적 제제 및 전문 의료 분야의 혁신은 많은 기회를 제공합니다. 또한, 치료제의 가격이 저렴해지고 반려동물과 가축에 대한 소비자의 인식이 높아지면서, 특히 신규 진출기업들에게 큰 성장 전망을 제공합니다.

이 보고서는 세계의 동물용 항감염제 시장을 조사했으며, 시장 개요와 함께 종별/약품 유형별/투여 모드별/유통 채널별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 조사하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter의 Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 동물용 항감염증제 시장 전망, 2018년-2031년

• 세계의 동물용 항감염증제 시장 전망, 종 유형별, 금액(100만 달러), 2018년-2031년
• 세계의 동물용 항감염증제 시장 전망, 약제 클래스별, 금액(100만 달러), 2018년-2031년
• 세계의 동물용 항감염증제 시장 전망, 투여 방법별, 금액(100만 달러), 2018년-2031년
• 세계의 동물용 항감염증제 시장 전망, 유통 채널별, 금액(100만 달러), 2018년-2031년
• 세계의 동물용 항감염증제 시장 전망, 지역별, 금액(100만 달러), 2018년-2031년

제4장 북미의 동물용 항감염증제 시장 전망, 2018년-2031년

제5장 유럽의 동물용 항감염증제 시장 전망, 2018년-2031년

제6장 아시아태평양의 동물용 항감염증제 시장 전망, 2018년-2031년

제7장 라틴아메리카의 동물용 항감염증제 시장 전망, 2018년-2031년

제8장 중동 및 아프리카의 동물용 항감염증제 시장 전망, 2018년-2031년

제9장 경쟁 구도

• 투여 모드별/약제 클래스별 히트맵
• 제조업체 및 약제 클래스별 히트맵
• 기업의 시장 점유율 분석, 2023년
• 경쟁력 대시보드
• 기업 개요
  • Bayer AG
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company(Elanco Animal Health)
  • Heska Corp(Diamond Animal Health)
  • Merck & Co., Inc.(Merck Animal Health)
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Sanofi(Merial Animal Health)
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Limited
  • Norbrook Laboratories Limited
  • Zydus Animal Health Limited
  • Ashish Life Science Private Limited
  • Oceanic Pharmachem Private Limited.

제10장 부록

LSH

영문 목차

영문목차

The global veterinary anti-infectives market is witnessing a significant shift in dynamics, with North America emerging as the most lucrative region. This trend can be attributed to the increasing pet ownership, a rising demand for enhanced animal nutrition, and a heightened focus on food safety. Furthermore, the adoption of pet insurance is on the rise, with enrollment in the United States growing at an impressive 10% per year.

North America: A Lucrative Hub The United States market leads the way in North America, expected to represent over 75% share during the forecast period. Canada is also set to exhibit robust growth with a projected CAGR of 4%. North America is expected to reach a market value share of more than US$ 1500 Mn.

Asia Pacific: Rapid Expansion Meanwhile, the Asia Pacific (APAC) region is experiencing rapid growth driven by the promotion of small animal care, a thriving livestock segment, and key players focusing on distribution partnerships in India.

Segment Insights: The antimicrobial agents segment leads the global veterinary anti-infectives market, closely followed by antiviral agents. Within the antimicrobial agents category, Penicillins, Cephalosporins, and Tetracyclines account for a higher growth rate. The antiviral agents segment is anticipated to be the second most lucrative segment by drug class, showcasing a market attractiveness index of 1.2 during the assessment period.

Unveiling Opportunities Biologics and specialty care present significant opportunities for key players in the global veterinary anti-infectives market. Past low returns on research and development have spurred a demand for New Product Development (NPD). Innovation in research and development, particularly in biologics and specialty care, offers a plethora of opportunities. Moreover, the increasing affordability of therapeutics and growing consumer awareness about pet care and livestock contribute to significant growth prospects, especially for new market entrants.

Comprehensive Market Segmentation The veterinary anti-infectives market research report provides a comprehensive segmentation based on several attributes:

1. By Region:

• North America
• Latin America
• Europe
• Asia Pacific (APAC)
• Middle East and Africa (MEA)

2. By Species Type:

• Livestock Animals
• Companion Animals

3. By Drug Class:

• Antimicrobial Agents
• Tetracyclines
• Penicillins
• Cephalosporins
• Macrolides
• Quinolones
• Others
• Antiviral Agents
• Antifungal Agents
• Antiparasitic Agents
• Others

4. By Mode of Administration:

• Oral
• Parenteral
• Topical

5. By Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies
• Others

These segmentation attributes enable a deeper understanding of market dynamics, regional variations, sub-segment analysis, and more.

Table of Contents

1. Executive Summary

• 1.1. Global Veterinary Anti-Infectives Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 3.1. Global Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Livestock Animals
    • 3.1.1.2. Companion Animals
• 3.2. Global Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Antimicrobial Agents
      • 3.2.1.1.1. Tetracyclines
      • 3.2.1.1.2. Penicillins
      • 3.2.1.1.3. Cephalosporins
      • 3.2.1.1.4. Macrolides
      • 3.2.1.1.5. Quinolones
      • 3.2.1.1.6. Others
    • 3.2.1.2. Antiviral Agents
    • 3.2.1.3. Antifungal Agents
    • 3.2.1.4. Antiparasitic Agents
    • 3.2.1.5. Others
• 3.3. Global Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. Oral
    • 3.3.1.2. Parenteral
    • 3.3.1.3. Topical
• 3.4. Global Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 3.4.1. Key Highlights
    • 3.4.1.1. Veterinary Hospitals
    • 3.4.1.2. Veterinary Clinics
    • 3.4.1.3. Pharmacies
    • 3.4.1.4. Others
• 3.5. Global Veterinary Anti-Infectives Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
  • 3.5.1. Key Highlights
    • 3.5.1.1. North America
    • 3.5.1.2. Europe
    • 3.5.1.3. Asia Pacific
    • 3.5.1.4. Latin America
    • 3.5.1.5. Middle East & Africa

4. North America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 4.1. North America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Livestock Animals
    • 4.1.1.2. Companion Animals
• 4.2. North America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Antimicrobial Agents
      • 4.2.1.1.1. Tetracyclines
      • 4.2.1.1.2. Penicillins
      • 4.2.1.1.3. Cephalosporins
      • 4.2.1.1.4. Macrolides
      • 4.2.1.1.5. Quinolones
      • 4.2.1.1.6. Others
    • 4.2.1.2. Antiviral Agents
    • 4.2.1.3. Antifungal Agents
    • 4.2.1.4. Antiparasitic Agents
    • 4.2.1.5. Others
• 4.3. North America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Oral
    • 4.3.1.2. Parenteral
    • 4.3.1.3. Topical
• 4.4. North America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. Veterinary Hospitals
    • 4.4.1.2. Veterinary Clinics
    • 4.4.1.3. Pharmacies
    • 4.4.1.4. Others
• 4.5. North America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 4.5.1. Key Highlights
    • 4.5.1.1. U.S. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 4.5.1.2. U.S. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 4.5.1.3. U.S. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 4.5.1.4. U.S. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 4.5.1.5. Canada Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 4.5.1.6. Canada Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 4.5.1.7. Canada Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 4.5.1.8. Canada Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 5.1. Europe Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Livestock Animals
    • 5.1.1.2. Companion Animals
• 5.2. Europe Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Antimicrobial Agents
      • 5.2.1.1.1. Tetracyclines
      • 5.2.1.1.2. Penicillins
      • 5.2.1.1.3. Cephalosporins
      • 5.2.1.1.4. Macrolides
      • 5.2.1.1.5. Quinolones
      • 5.2.1.1.6. Others
    • 5.2.1.2. Antiviral Agents
    • 5.2.1.3. Antifungal Agents
    • 5.2.1.4. Antiparasitic Agents
    • 5.2.1.5. Others
• 5.3. Europe Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Oral
    • 5.3.1.2. Parenteral
    • 5.3.1.3. Topical
• 5.4. Europe Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. Veterinary Hospitals
    • 5.4.1.2. Veterinary Clinics
    • 5.4.1.3. Pharmacies
    • 5.4.1.4. Others
• 5.5. Europe Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 5.5.1. Key Highlights
    • 5.5.1.1. Germany Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.2. Germany Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.3. Germany Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.4. Germany Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.5. U.K. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.6. U.K. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.7. U.K. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.8. U.K. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.9. France Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.10. France Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.11. France Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.12. France Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.13. Italy Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.14. Italy Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.15. Italy Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.16. Italy Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.17. Turkey Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.18. Turkey Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.19. Turkey Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.20. Turkey Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.21. Russia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.22. Russia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.23. Russia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.24. Russia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.1.25. Rest of Europe Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.5.1.26. Rest of Europe Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.5.1.27. Rest of Europe Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.5.1.28. Rest of Europe Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Livestock Animals
    • 6.1.1.2. Companion Animals
• 6.2. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Antimicrobial Agents
      • 6.2.1.1.1. Tetracyclines
      • 6.2.1.1.2. Penicillins
      • 6.2.1.1.3. Cephalosporins
      • 6.2.1.1.4. Macrolides
      • 6.2.1.1.5. Quinolones
      • 6.2.1.1.6. Others
    • 6.2.1.2. Antiviral Agents
    • 6.2.1.3. Antifungal Agents
    • 6.2.1.4. Antiparasitic Agents
    • 6.2.1.5. Others
• 6.3. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Oral
    • 6.3.1.2. Parenteral
    • 6.3.1.3. Topical
• 6.4. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. Veterinary Hospitals
    • 6.4.1.2. Veterinary Clinics
    • 6.4.1.3. Pharmacies
    • 6.4.1.4. Others
• 6.5. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 6.5.1. Key Highlights
    • 6.5.1.1. China Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.2. China Veterinary Anti-Infectives Market Sample Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.3. China Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.4. China Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.1.5. Japan Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.6. Japan Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.5.1.7. Japan Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.8. Japan Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.1.9. South Korea Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.10. South Korea Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.5.1.11. South Korea Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.12. South Korea Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.1.13. India Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.14. India Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.5.1.15. India Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.16. India Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.1.17. Southeast Asia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.18. Southeast Asia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.5.1.19. Southeast Asia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.20. Southeast Asia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.1.21. Rest of Asia Pacific Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.5.1.22. Rest of Asia Pacific Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.5.1.23. Rest of Asia Pacific Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.5.1.24. Rest of Asia Pacific Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 7.1. Latin America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Livestock Animals
    • 7.1.1.2. Companion Animals
• 7.2. Latin America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Antimicrobial Agents
      • 7.2.1.1.1. Tetracyclines
      • 7.2.1.1.2. Penicillins
      • 7.2.1.1.3. Cephalosporins
      • 7.2.1.1.4. Macrolides
      • 7.2.1.1.5. Quinolones
      • 7.2.1.1.6. Others
    • 7.2.1.2. Antiviral Agents
    • 7.2.1.3. Antifungal Agents
    • 7.2.1.4. Antiparasitic Agents
    • 7.2.1.5. Others
• 7.3. Latin America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Oral
    • 7.3.1.2. Parenteral
    • 7.3.1.3. Topical
• 7.4. Latin America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Veterinary Hospitals
    • 7.4.1.2. Veterinary Clinics
    • 7.4.1.3. Pharmacies
    • 7.4.1.4. Others
• 7.5. Latin America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 7.5.1. Key Highlights
    • 7.5.1.1. Brazil Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.5.1.2. Brazil Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.5.1.3. Brazil Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.5.1.4. Brazil Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.5.1.5. Mexico Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.5.1.6. Mexico Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.5.1.7. Mexico Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.5.1.8. Mexico Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.5.1.9. Argentina Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.5.1.10. Argentina Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.5.1.11. Argentina Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.5.1.12. Argentina Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.5.1.13. Rest of Latin America Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.5.1.14. Rest of Latin America Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.5.1.15. Rest of Latin America Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.5.1.16. Rest of Latin America Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Veterinary Anti-Infectives Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Livestock Animals
    • 8.1.1.2. Companion Animals
• 8.2. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Antimicrobial Agents
      • 8.2.1.1.1. Tetracyclines
      • 8.2.1.1.2. Penicillins
      • 8.2.1.1.3. Cephalosporins
      • 8.2.1.1.4. Macrolides
      • 8.2.1.1.5. Quinolones
      • 8.2.1.1.6. Others
    • 8.2.1.2. Antiviral Agents
    • 8.2.1.3. Antifungal Agents
    • 8.2.1.4. Antiparasitic Agents
    • 8.2.1.5. Others
• 8.3. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Oral
    • 8.3.1.2. Parenteral
    • 8.3.1.3. Topical
• 8.4. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. Veterinary Hospitals
    • 8.4.1.2. Veterinary Clinics
    • 8.4.1.3. Pharmacies
    • 8.4.1.4. Others
• 8.5. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 8.5.1. Key Highlights
    • 8.5.1.1. GCC Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.5.1.2. GCC Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.5.1.3. GCC Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.5.1.4. GCC Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.1.5. South Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.5.1.6. South Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.5.1.7. South Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.5.1.8. South Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.1.9. Egypt Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.5.1.10. Egypt Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.5.1.11. Egypt Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.5.1.12. Egypt Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.1.13. Nigeria Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.5.1.14. Nigeria Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.5.1.15. Nigeria Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.5.1.16. Nigeria Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.1.17. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.5.1.18. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.5.1.19. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.5.1.20. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. by Mode of Administration vs by Drug Class Heatmap
• 9.2. Manufacturer vs by Drug Class Heatmap
• 9.3. Company Market Share Analysis, 2023
• 9.4. Competitive Dashboard
• 9.5. Company Profiles
  • 9.5.1. Bayer AG
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Product Portfolio
    • 9.5.1.3. Financial Overview
    • 9.5.1.4. Business Strategies and Development
  • 9.5.2. Cipla Limited
    • 9.5.2.1. Company Overview
    • 9.5.2.2. Product Portfolio
    • 9.5.2.3. Financial Overview
    • 9.5.2.4. Business Strategies and Development
  • 9.5.3. Dechra Pharmaceuticals PLC
    • 9.5.3.1. Company Overview
    • 9.5.3.2. Product Portfolio
    • 9.5.3.3. Financial Overview
    • 9.5.3.4. Business Strategies and Development
  • 9.5.4. Eli Lilly and Company (Elanco Animal Health)
    • 9.5.4.1. Company Overview
    • 9.5.4.2. Product Portfolio
    • 9.5.4.3. Financial Overview
    • 9.5.4.4. Business Strategies and Development
  • 9.5.5. Heska Corp (Diamond Animal Health)
    • 9.5.5.1. Company Overview
    • 9.5.5.2. Product Portfolio
    • 9.5.5.3. Financial Overview
    • 9.5.5.4. Business Strategies and Development
  • 9.5.6. Merck & Co., Inc. (Merck Animal Health)
    • 9.5.6.1. Company Overview
    • 9.5.6.2. Product Portfolio
    • 9.5.6.3. Financial Overview
    • 9.5.6.4. Business Strategies and Development
  • 9.5.7. Neogen Corporation
    • 9.5.7.1. Company Overview
    • 9.5.7.2. Product Portfolio
    • 9.5.7.3. Financial Overview
    • 9.5.7.4. Business Strategies and Development
  • 9.5.8. Phibro Animal Health Corporation
    • 9.5.8.1. Company Overview
    • 9.5.8.2. Product Portfolio
    • 9.5.8.3. Financial Overview
    • 9.5.8.4. Business Strategies and Development
  • 9.5.9. Sanofi (Merial Animal Health)
    • 9.5.9.1. Company Overview
    • 9.5.9.2. Product Portfolio
    • 9.5.9.3. Financial Overview
    • 9.5.9.4. Business Strategies and Development
  • 9.5.10. Vetoquinol S.A.
    • 9.5.10.1. Company Overview
    • 9.5.10.2. Product Portfolio
    • 9.5.10.3. Financial Overview
    • 9.5.10.4. Business Strategies and Development
  • 9.5.11. Virbac S.A.
    • 9.5.11.1. Company Overview
    • 9.5.11.2. Product Portfolio
    • 9.5.11.3. Financial Overview
    • 9.5.11.4. Business Strategies and Development
  • 9.5.12. Zoetis, Inc.
    • 9.5.12.1. Company Overview
    • 9.5.12.2. Product Portfolio
    • 9.5.12.3. Financial Overview
    • 9.5.12.4. Business Strategies and Development
  • 9.5.13. Boehringer Ingelheim GmbH
    • 9.5.13.1. Company Overview
    • 9.5.13.2. Product Portfolio
    • 9.5.13.3. Financial Overview
    • 9.5.13.4. Business Strategies and Development
  • 9.5.14. Ceva Sante Animale
    • 9.5.14.1. Company Overview
    • 9.5.14.2. Product Portfolio
    • 9.5.14.3. Financial Overview
    • 9.5.14.4. Business Strategies and Development
  • 9.5.15. Indian Immunologicals Limited
    • 9.5.15.1. Company Overview
    • 9.5.15.2. Product Portfolio
    • 9.5.15.3. Financial Overview
    • 9.5.15.4. Business Strategies and Development
  • 9.5.16. Intas Pharmaceuticals Limited
    • 9.5.16.1. Company Overview
    • 9.5.16.2. Product Portfolio
    • 9.5.16.3. Financial Overview
    • 9.5.16.4. Business Strategies and Development
  • 9.5.17. Norbrook Laboratories Limited
    • 9.5.17.1. Company Overview
    • 9.5.17.2. Product Portfolio
    • 9.5.17.3. Financial Overview
    • 9.5.17.4. Business Strategies and Development
  • 9.5.18. Zydus Animal Health Limited
    • 9.5.18.1. Company Overview
    • 9.5.18.2. Product Portfolio
    • 9.5.18.3. Financial Overview
    • 9.5.18.4. Business Strategies and Development
  • 9.5.19. Ashish Life Science Private Limited
    • 9.5.19.1. Company Overview
    • 9.5.19.2. Product Portfolio
    • 9.5.19.3. Financial Overview
    • 9.5.19.4. Business Strategies and Development
  • 9.5.20. Oceanic Pharmachem Private Limited.
    • 9.5.20.1. Company Overview
    • 9.5.20.2. Product Portfolio
    • 9.5.20.3. Financial Overview
    • 9.5.20.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료